BioPlus Acquisition (BIOS) stock Forecast for 2022 – 2026

BioPlus Acquisition (BIOS) stock Forecast for 2022 – 2026

Last update: October 6, 2022 (07:40)

Sector: Financial

The share price of BioPlus Acquisition Corp. (BIOS) now

What analysts predict: $20

52-week high/low: $10.14 / $9.78

50/200 Day Moving Average: $10.01 / $9.94

This figure corresponds to the average price over the previous 50/200 days. For BioPlus Acquisition stocks, the 50-day moving average is the support level today.

For BioPlus Acquisition stocks, the 200-day moving average is the support level today.

Are you interested in BioPlus Acquisition Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BioPlus Acquisition stock price in 2022, 2023, 2024, 2025, 2026. How much will one BioPlus Acquisition share be worth in 2022 - 2026?

When should I take profit in BioPlus Acquisition stock? When should I record a loss on BioPlus Acquisition stock? What are analysts' forecasts for BioPlus Acquisition stock? What is the future of BioPlus Acquisition stock?

We forecast BioPlus Acquisition stock performance using neural networks based on historical data on BioPlus Acquisition stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

BioPlus Acquisition stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BioPlus Acquisition shares. This happens once a day.





Historical and forecast chart of BioPlus Acquisition stock

The chart below shows the historical price of BioPlus Acquisition stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BioPlus Acquisition stock price can be found in the table below.

Long-term forecasts by years.

BioPlus Acquisition daily forecast for a month

Date Target Pes. Opt. Vol., %
Oct 08 10.12 9.89 10.28 4.01
Oct 09 10.18 10.05 10.33 2.69
Oct 10 9.86 9.74 10.07 3.42
Oct 11 9.62 9.41 9.69 2.95
Oct 12 9.98 9.75 10.09 3.46
Oct 13 10.09 9.95 10.23 2.85
Oct 14 9.92 9.65 10.02 3.79
Oct 15 9.92 9.69 10.00 3.23
Oct 16 10.11 9.91 10.40 4.96
Oct 17 9.84 9.74 9.92 1.80
Oct 18 9.85 9.73 10.06 3.42
Oct 19 10.20 9.93 10.39 4.64
Oct 20 10.56 10.40 10.83 4.21
Oct 21 10.60 10.31 10.69 3.75
Oct 22 10.56 10.28 10.84 5.43
Oct 23 10.46 10.27 10.60 3.21
Oct 24 10.42 10.21 10.72 5.01
Oct 25 10.66 10.46 10.88 3.95
Oct 26 10.84 10.52 11.09 5.44
Oct 27 10.74 10.47 11.05 5.54
Oct 28 10.76 10.56 11.01 4.18
Oct 29 10.38 10.27 10.55 2.69
Oct 30 10.62 10.39 10.79 3.92
Oct 31 10.74 10.46 11.03 5.42
Nov 01 10.89 10.69 11.01 2.98
Nov 02 10.73 10.61 11.03 3.96
Nov 03 10.65 10.46 10.74 2.67
Nov 04 10.48 10.26 10.73 4.54
Nov 05 10.58 10.37 10.76 3.76
Nov 06 10.21 9.96 10.33 3.74

BioPlus Acquisition Daily Price Targets


BioPlus Acquisition Stock Forecast 10-08-2022.

Forecast target price for 10-08-2022: $10.12. Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 3.852%.

Pessimistic target level: 9.89

Optimistic target level: 10.28


BioPlus Acquisition Stock Forecast 10-09-2022.

Forecast target price for 10-09-2022: $10.18. Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 2.623%.

Pessimistic target level: 10.05

Optimistic target level: 10.33


BioPlus Acquisition Stock Forecast 10-10-2022.

Forecast target price for 10-10-2022: $9.86. Negative dynamics for BioPlus Acquisition shares will prevail with possible volatility of 3.311%.

Pessimistic target level: 9.74

Optimistic target level: 10.07


BioPlus Acquisition Stock Forecast 10-11-2022.

Forecast target price for 10-11-2022: $9.62. Negative dynamics for BioPlus Acquisition shares will prevail with possible volatility of 2.866%.

Pessimistic target level: 9.41

Optimistic target level: 9.69


BioPlus Acquisition Stock Forecast 10-12-2022.

Forecast target price for 10-12-2022: $9.98. Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 3.348%.

Pessimistic target level: 9.75

Optimistic target level: 10.09


BioPlus Acquisition Stock Forecast 10-13-2022.

Forecast target price for 10-13-2022: $10.09. Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 2.774%.

Pessimistic target level: 9.95

Optimistic target level: 10.23


BIOS (BIOS) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Nov. 10.06 9.46 10.77 12.23
Dec. 9.58 9.23 10.13 8.88

BioPlus Acquisition forecast for this year


BioPlus Acquisition Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $10.0597. Pessimistic: $9.46. Optimistic: $10.77


BioPlus Acquisition Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $9.57688. Pessimistic: $9.23. Optimistic: $10.13




BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 9.37 9.16 10.08 9.11
Feb 9.15 8.63 9.58 9.93
Mar 9.21 8.84 9.80 9.78
Apr 9.33 8.64 9.56 9.66
May 9.85 9.56 10.52 9.08
Jun 10.03 9.58 10.73 10.66
Jul 10.27 9.51 10.74 11.47
Aug 11.11 10.36 11.46 9.59
Sep 10.73 10.17 11.43 10.99
Oct 10.90 10.55 11.42 7.63
Nov 11.04 10.76 11.45 6.08
Dec 10.87 10.30 11.42 9.80

BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 11.14 10.60 12.01 11.69
Feb 11.08 10.63 11.64 8.67
Mar 11.55 11.10 12.10 8.30
Apr 12.30 11.68 12.64 7.59
May 12.84 11.98 13.12 8.71
Jun 12.00 11.58 12.95 10.56
Jul 11.07 10.47 11.88 11.84
Aug 11.31 11.02 11.84 6.97
Sep 11.67 11.08 12.13 8.66
Oct 11.55 10.69 11.96 10.62
Nov 12.35 11.60 12.66 8.39
Dec 12.82 11.89 13.63 12.79



BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 13.39 12.97 14.27 9.10
Feb 13.99 13.51 14.49 6.76
Mar 14.20 13.52 15.24 11.28
Apr 12.81 11.81 13.53 12.69
May 12.95 11.93 13.39 10.93
Jun 12.53 12.12 13.10 7.46
Jul 12.77 12.12 13.36 9.27
Aug 13.76 13.18 14.36 8.24
Sep 14.71 13.60 15.53 12.41
Oct 14.79 14.44 15.56 7.22
Nov 14.90 14.58 15.23 4.21
Dec 15.40 15.05 16.51 8.86

BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 15.39 14.83 15.73 5.67
Feb 15.16 14.57 15.67 7.06
Mar 14.85 13.79 15.72 12.29
Apr 15.09 14.53 15.50 6.23
May 15.62 15.03 16.01 6.15
Jun 15.60 15.00 16.21 7.51
Jul 15.03 14.16 15.66 9.60
Aug 15.96 15.51 16.42 5.54
Sep 17.01 16.49 17.80 7.36
Oct 18.44 17.45 19.51 10.59
Nov 19.57 18.61 20.96 11.20
Dec 19.12 18.68 20.23 7.66

BioPlus Acquisition information and performance

BioPlus Acquisition Corp. operates as a blank check company. It is created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on February 11, 2021 and is headquartered in New York, NY.

BioPlus Acquisition Address

260 MADISON AVENUE, SUITE 800, NEW YORK, NY, UNITED STATES

Market Capitalization: 294 557 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: None

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 23560000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Financial sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.